REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 11,100
+40 (0.36%)
Last updated: Apr 24, 2026, 3:00 PM KST
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 202.85 billion as of April 24, 2026. Its market cap has decreased by -1.34% in one year.
Market Cap
202.85B
Enterprise Value
412.18B
Revenue
145.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,100.00
Market Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 202.85B, an increase of 23.27%. That is a compound annual growth rate of 1.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 201.38B | 1.86% |
| Dec 30, 2025 | 197.72B | -16.04% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai Pharmaceutical | 236.92B |
| Daewon Pharmaceutical | 234.27B |
| Samjin Pharmaceuticals | 232.04B |
| Suheung | 219.16B |
| Ilyang Pharmaceutical Co.,Ltd | 212.23B |
| Samil Pharmaceutical Co.,Ltd | 203.59B |
| AptaBio Therapeutics | 202.55B |
| Jeil Pharmaceutical Co.,Ltd | 202.54B |